These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 15705642

  • 1. Clonal spread of fluoroquinolone non-susceptible Streptococcus pyogenes.
    Malhotra-Kumar S, Lammens C, Chapelle S, Mallentjer C, Weyler J, Goossens H.
    J Antimicrob Chemother; 2005 Mar; 55(3):320-5. PubMed ID: 15705642
    [Abstract] [Full Text] [Related]

  • 2. Emergence of high-level fluoroquinolone resistance in emm6 Streptococcus pyogenes and in vitro resistance selection with ciprofloxacin, levofloxacin and moxifloxacin.
    Malhotra-Kumar S, Van Heirstraeten L, Lammens C, Chapelle S, Goossens H.
    J Antimicrob Chemother; 2009 May; 63(5):886-94. PubMed ID: 19279051
    [Abstract] [Full Text] [Related]

  • 3. Increase in fluoroquinolone non-susceptibility among clinical Streptococcus pyogenes in Belgium during 2007-10.
    Van Heirstraeten L, Leten G, Lammens C, Goossens H, Malhotra-Kumar S.
    J Antimicrob Chemother; 2012 Nov; 67(11):2602-5. PubMed ID: 22815354
    [Abstract] [Full Text] [Related]

  • 4. Emerging fluoroquinolone-non-susceptible group A streptococci in two different paediatric populations.
    Smeesters PR, Vergison A, Junior DC, Van Melderen L.
    Int J Antimicrob Agents; 2009 Jul; 34(1):44-9. PubMed ID: 19269141
    [Abstract] [Full Text] [Related]

  • 5. Intrinsic reduced susceptibility of serotype 6 Streptococcus pyogenes to fluoroquinolone antibiotics.
    Orscheln RC, Johnson DR, Olson SM, Presti RM, Martin JM, Kaplan EL, Storch GA.
    J Infect Dis; 2005 Apr 15; 191(8):1272-9. PubMed ID: 15776373
    [Abstract] [Full Text] [Related]

  • 6. In vitro induction and selection of fluoroquinolone-resistant mutants of Streptococcus pyogenes strains with multiple emm types.
    Billal DS, Fedorko DP, Yan SS, Hotomi M, Fujihara K, Nelson N, Yamanaka N.
    J Antimicrob Chemother; 2007 Jan 15; 59(1):28-34. PubMed ID: 17065188
    [Abstract] [Full Text] [Related]

  • 7. Fluoroquinolone resistance in invasive Streptococcus pyogenes isolates due to spontaneous mutation and horizontal gene transfer.
    Pletz MW, McGee L, Van Beneden CA, Petit S, Bardsley M, Barlow M, Klugman KP.
    Antimicrob Agents Chemother; 2006 Mar 15; 50(3):943-8. PubMed ID: 16495255
    [Abstract] [Full Text] [Related]

  • 8. Emergence and epidemiology of fluoroquinolone-resistant Streptococcus pneumoniae strains from Italy: report from the SENTRY Antimicrobial Surveillance Program (2001-2004).
    Deshpande LM, Sader HS, Debbia E, Nicoletti G, Fadda G, Jones RN, SENTRY Antimicrobial Surveillance Program (2001-2004).
    Diagn Microbiol Infect Dis; 2006 Mar 15; 54(3):157-64. PubMed ID: 16423493
    [Abstract] [Full Text] [Related]

  • 9. Macrolide-resistant Streptococcus pyogenes in the United States, 2002-2003.
    Richter SS, Heilmann KP, Beekmann SE, Miller NJ, Miller AL, Rice CL, Doern CD, Reid SD, Doern GV.
    Clin Infect Dis; 2005 Sep 01; 41(5):599-608. PubMed ID: 16080080
    [Abstract] [Full Text] [Related]

  • 10. Cross-resistance, relatedness and allele analysis of fluoroquinolone-resistant US clinical isolates of Streptococcus pneumoniae (1998-2000).
    Davies TA, Goldschmidt R, Pfleger S, Loeloff M, Bush K, Sahm DF, Evangelista A.
    J Antimicrob Chemother; 2003 Aug 01; 52(2):168-75. PubMed ID: 12837740
    [Abstract] [Full Text] [Related]

  • 11. Characterization of levofloxacin non-susceptible clinical Streptococcus pyogenes isolated in the central part of Italy.
    Petrelli D, Di Luca MC, Prenna M, Bernaschi P, Repetto A, Vitali LA.
    Eur J Clin Microbiol Infect Dis; 2014 Feb 01; 33(2):241-4. PubMed ID: 24002218
    [Abstract] [Full Text] [Related]

  • 12. Are fluoroquinolone-susceptible isolates of Streptococcus pneumoniae really susceptible? A comparison of resistance mechanisms in Canadian isolates from 1997 and 2003.
    Schurek KN, Adam HJ, Siemens CG, Hoban CJ, Hoban DJ, Zhanel GG.
    J Antimicrob Chemother; 2005 Oct 01; 56(4):769-72. PubMed ID: 16126779
    [Abstract] [Full Text] [Related]

  • 13. Prevalence and clonal characterization of Streptococcus pyogenes clinical isolates with reduced fluoroquinolone susceptibility in Spain.
    Montes M, Tamayo E, Orden B, Larruskain J, Perez-Trallero E.
    Antimicrob Agents Chemother; 2010 Jan 01; 54(1):93-7. PubMed ID: 19805559
    [Abstract] [Full Text] [Related]

  • 14. Role of type II topoisomerase mutations and AcrAB efflux pump in fluoroquinolone-resistant clinical isolates of Proteus mirabilis.
    Saito R, Sato K, Kumita W, Inami N, Nishiyama H, Okamura N, Moriya K, Koike K.
    J Antimicrob Chemother; 2006 Sep 01; 58(3):673-7. PubMed ID: 16870650
    [Abstract] [Full Text] [Related]

  • 15. Molecular epidemiology, antimicrobial susceptibility, and characterization of fluoroquinolone non-susceptible Streptococcus pyogenes in Japan.
    Tatara K, Gotoh K, Okumiya K, Teramachi M, Ishimoto K, Tanaka Y, Iwahashi J, Shindou S, Yamashita Y, Watanabe H.
    J Infect Chemother; 2020 Mar 01; 26(3):280-284. PubMed ID: 31680034
    [Abstract] [Full Text] [Related]

  • 16. Molecular mechanisms of decreased susceptibility to fluoroquinolones in avian Salmonella serovars and their mutants selected during the determination of mutant prevention concentrations.
    Kehrenberg C, de Jong A, Friederichs S, Cloeckaert A, Schwarz S.
    J Antimicrob Chemother; 2007 May 01; 59(5):886-92. PubMed ID: 17369276
    [Abstract] [Full Text] [Related]

  • 17. Antimicrobial resistance of nasopharyngeal pneumococci from children from day-care centres and orphanages in Russia: results of a unique prospective multicentre study.
    Stratchounski LS, Kozlov RS, Appelbaum PC, Kretchikova OI, Kosowska-Shick K.
    Clin Microbiol Infect; 2006 Sep 01; 12(9):853-66. PubMed ID: 16882290
    [Abstract] [Full Text] [Related]

  • 18. TARGETed surveillance: susceptibility of Streptococcus pneumoniae isolated from community-acquired respiratory tract infections in 2003 to fluoroquinolones and other agents.
    Morrissey I, Colclough A, Northwood J.
    Int J Antimicrob Agents; 2007 Oct 01; 30(4):345-51. PubMed ID: 17643269
    [Abstract] [Full Text] [Related]

  • 19. Characterization of fluoroquinolone-resistant beta-hemolytic Streptococcus spp. isolated in North America and Europe including the first report of fluoroquinolone-resistant Streptococcus dysgalactiae subspecies equisimilis: report from the SENTRY Antimicrobial Surveillance Program (1997-2004).
    Biedenbach DJ, Toleman MA, Walsh TR, Jones RN.
    Diagn Microbiol Infect Dis; 2006 Jun 01; 55(2):119-27. PubMed ID: 16530373
    [Abstract] [Full Text] [Related]

  • 20. High prevalence of fluoroquinolone-nonsusceptible Streptococcus pyogenes emm12 in Taiwan.
    Lin JN, Chang LL, Lai CH, Huang YH, Chen WF, Yang CH, Hsu J, Lin HH, Chen YH.
    Diagn Microbiol Infect Dis; 2015 Oct 01; 83(2):187-92. PubMed ID: 26234479
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.